| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.09 |